News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
108,548 Results
Type
Article (4585)
Company Profile (27)
Press Release (103936)
Multimedia
Podcasts (10)
Webinars (1)
Section
Business (40686)
Career Advice (115)
Deals (7013)
Drug Delivery (20)
Drug Development (13240)
Employer Resources (15)
FDA (2495)
Job Trends (3332)
News (61670)
Policy (4265)
Tag
Academia (351)
Accelerated approval (4)
Allergies (31)
Alliances (4669)
ALS (27)
Alzheimer's disease (254)
Antibody-drug conjugate (ADC) (46)
Approvals (2601)
Artificial intelligence (48)
Autoimmune disease (16)
Automation (5)
Bankruptcy (53)
Best Places to Work (2905)
BIOSECURE Act (2)
Biosimilars (26)
Biotechnology (17)
Bladder cancer (46)
Brain cancer (9)
Breast cancer (141)
Cancer (952)
Cardiovascular disease (72)
Career advice (103)
Career pathing (2)
CAR-T (28)
CDC (4)
Cell therapy (98)
Cervical cancer (5)
Clinical research (12059)
Collaboration (179)
Company closure (1)
Compensation (108)
Complete response letters (4)
COVID-19 (383)
CRISPR (18)
C-suite (57)
Cystic fibrosis (14)
Data (1322)
Depression (21)
Diabetes (78)
Diagnostics (1091)
Digital health (5)
Diversity, equity & inclusion (2)
Drug discovery (29)
Drug pricing (33)
Drug shortages (1)
Duchenne muscular dystrophy (29)
Earnings (33051)
Editorial (7)
Employer branding (3)
Employer resources (13)
Events (14313)
Executive appointments (91)
FDA (3220)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (2)
Frontotemporal dementia (7)
Funding (176)
Gene editing (37)
Generative AI (5)
Gene therapy (76)
GLP-1 (149)
Government (683)
Grass and pollen (2)
Guidances (291)
Healthcare (3341)
HIV (28)
Huntington's disease (5)
IgA nephropathy (19)
Immunology and inflammation (33)
Immuno-oncology (3)
Indications (17)
Infectious disease (428)
Inflammatory bowel disease (35)
Inflation Reduction Act (3)
Influenza (18)
Intellectual property (19)
Interviews (14)
IPO (4481)
IRA (8)
Job creations (549)
Job search strategy (91)
Kidney cancer (1)
Labor market (27)
Layoffs (119)
Leadership (1)
Legal (677)
Liver cancer (17)
Longevity (1)
Lung cancer (151)
Lymphoma (85)
Machine learning (4)
Management (5)
Manufacturing (74)
MASH (50)
Medical device (2513)
Medtech (2524)
Mergers & acquisitions (2690)
Metabolic disorders (215)
Multiple sclerosis (28)
NASH (4)
Neurodegenerative disease (36)
Neuropsychiatric disorders (15)
Neuroscience (442)
NextGen: Class of 2025 (902)
Non-profit (510)
Now hiring (4)
Obesity (82)
Opinion (26)
Ovarian cancer (30)
Pain (21)
Pancreatic cancer (24)
Parkinson's disease (36)
Partnered (4)
Patents (38)
Patient recruitment (39)
Peanut (13)
People (4778)
Pharmaceutical (3)
Pharmacy benefit managers (7)
Phase I (2837)
Phase II (5073)
Phase III (5084)
Pipeline (1638)
Policy (42)
Postmarket research (473)
Preclinical (920)
Press Release (5)
Prostate cancer (45)
Psychedelics (8)
Radiopharmaceuticals (42)
Rare diseases (120)
Real estate (699)
Recruiting (7)
Regulatory (3549)
Reports (13)
Research institute (288)
Resumes & cover letters (16)
Rett syndrome (5)
RNA editing (2)
RSV (18)
Schizophrenia (40)
Series A (22)
Series B (19)
Service/supplier (1)
Sickle cell disease (20)
Special edition (6)
Spinal muscular atrophy (32)
Sponsored (9)
Startups (377)
Stomach cancer (2)
Supply chain (5)
Tariffs (15)
The Weekly (10)
Vaccines (158)
Venture capital (11)
Weight loss (49)
Women's health (12)
Worklife (2)
Date
Today (15)
Last 7 days (89)
Last 30 days (414)
Last 365 days (6763)
2025 (6638)
2024 (7137)
2023 (8390)
2022 (9456)
2021 (10000)
2020 (8988)
2019 (7616)
2018 (5870)
2017 (5190)
2016 (4536)
2015 (5926)
2014 (3667)
2013 (2500)
2012 (2628)
2011 (3194)
2010 (3259)
Location
Africa (94)
Alabama (10)
Arizona (28)
Asia (6057)
Australia (777)
California (2293)
Canada (597)
China (150)
Colorado (88)
Connecticut (108)
Delaware (98)
Europe (16409)
Florida (238)
Georgia (81)
Idaho (10)
Illinois (174)
India (7)
Indiana (114)
Iowa (3)
Japan (119)
Kansas (17)
Kentucky (12)
Louisiana (11)
Maine (22)
Maryland (243)
Massachusetts (1461)
Michigan (41)
Minnesota (110)
Mississippi (1)
Missouri (22)
Montana (4)
Nebraska (1)
Nevada (21)
New Hampshire (20)
New Jersey (803)
New York (729)
North Carolina (277)
North Dakota (2)
Northern California (1167)
Ohio (41)
Oklahoma (3)
Oregon (5)
Pennsylvania (461)
Puerto Rico (1)
Rhode Island (5)
South America (147)
South Carolina (5)
Southern California (902)
Tennessee (21)
Texas (261)
United States (7952)
Utah (147)
Virginia (30)
Washington D.C. (12)
Washington State (170)
Wisconsin (14)
Wyoming (1)
108,548 Results for "35".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioMark Diagnostics Collaborative Lung Cancer Screening Project Honored by ADRIQ during the 35th Innovation Awards Gala
Recognition of BioMark Leadership in Early Cancer Detection Validates Commercialization Trajectory of Multimodal Lung Cancer Screening Platform
December 1, 2025
·
4 min read
Press Releases
ABK Biomedical Raises US$35M in Series D Financing
October 15, 2025
·
3 min read
Press Releases
Stem Cell Banking Market to Worth USD 35.12 Billion, Forecasts 16.14% CAGR by 2034
October 22, 2025
·
1 min read
Press Releases
Alpha Cognition Inc. Announces Pricing of $35 Million Oversubscribed Public Offering of Common Shares
October 1, 2025
·
6 min read
Mergers & acquisitions
Roche Makes Major MASH Move With $3.5B 89bio Buy
The star of the acquisition, which includes a contingent value right of $6 per share, is pegozafermin, an FGF21 analog in late-stage development for metabolic dysfunction-associated steatohepatitis.
September 18, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Tempest Announces Closing of Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules
November 27, 2025
·
5 min read
Press Releases
Hoth Therapeutics CEO Robb Knie to Present at BIO-Europe in Vienna, Austria November 3-5, 2025
October 8, 2025
·
4 min read
Mergers & acquisitions
How Akero’s MASH Success Drove Roche’s $3.5B Takeout of 89bio
Regulatory documents show how 89bio’s board pushed Roche hard for a deal valued at $20 per share in upfront and milestone payments.
October 2, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
Octave Bioscience Announces $35M Series C Financing to Accelerate Commercial Momentum
September 5, 2025
·
2 min read
Press Releases
Sanofi expands patient affordability program by offering access to all its insulins for $35 per month in the US
September 29, 2025
·
5 min read
1 of 10,855
Next
